Kendomycin is an antitumor macrolide antibiotic first isolated from the bacteria Streptomyces violaceoruber. It has potent activity as an endothelin receptor antagonist and anti-osteoporosis agent.It also has strong cytotoxicity against various tumor cell lines.
This page contains content from the copyrighted Wikipedia article "Kendomycin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
